Speaker illustration

Doctor Anna Planavila

University of Barcelona, Barcelona (Spain)

FGF15/FGF19 is involved in the development of cardiac hypertrophy

Event: Frontiers in CardioVascular Biomedicine 2022

Topic: Cardiac Hypertrophy

Session: Poster Session 1

Thumbnail

Involvement of the Fgf21 system in obesity-associated cardiomyopathy

Event: Frontiers in CardioVascular Biology 2016

Topic: Metabolism / Diabetes mellitus

Session: Obesity and cardiac microvascular function

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb